Industry News
Listed below is the most recent news in the drug industry. You will find press releases and announcements from large pharmaceuticals as well as from the FDA and other sources. The news is sorted by date as it is released, giving you immediate access to the most relevant information — all in one place. Bookmark this page if you'd like to keep current on the news in the drug industry.
Channel: Drugs.com - Pharma News+ show more articles - show fewer articles
- Sep 03, 2010: Cardiome Achieves $30 Million Milestone
- Sep 03, 2010: Roche Announces Operational Excellence Initiative
- Sep 03, 2010: Novartis and Collaborators Discover Novel Antimalarial Drug Candidate
- Sep 03, 2010: Long term use of oral bisphosphonates may double risk of esophageal cancer
- Sep 03, 2010: Pfizer Ends Brain Cancer Drug Deal With Celldex
- Sep 03, 2010: CDC: Prescription Drug Use Continues to Increase: U.S. Prescription Drug Data for 2007-2008
- Sep 03, 2010: Merck?s Cladribine Tablets for Multiple Sclerosis Approved in Australia
- Sep 03, 2010: Abbott Calls Off Sale of Flu Vaccine Business In Europe
- Sep 02, 2010: Study Reinforces Long-Known Dangers of Weight-Loss Drug Meridia
- Sep 02, 2010: K-V Pharmaceutical Company Receives Notification From New York Stock Exchange of Compliance With Quantitative Continued Listing Standards
- Sep 02, 2010: SEC Charges Pharmaceutical Company Insider and Former Hedge Fund Manager for Insider Trading, Resulting in Approximately $14 Million in Profits
- Sep 02, 2010: Orexigen Therapeutics and Takeda Enter Into Partnership to Commercialize Contrave in North America
- Sep 02, 2010: FDA Drug Safety Communication: Increased Risk of Death with Tygacil (tigecycline) Compared to Other Antibiotics Used to Treat Similar Infections
- Sep 01, 2010: Court Affirms Eli Lilly Patents Protecting Evista
- Sep 01, 2010: U.S. Court of Appeals Upholds Validity of Lilly's Evista Patents Through March of 2014
- Sep 01, 2010: ZS Pharma To Get $2 Million From Texas
- Sep 01, 2010: FDA MedWatch - Tygacil (tigecycline): Label Change - Increased Mortality Risk
- Sep 01, 2010: Novo Nordisk Creates ?App? to Help Doctors Dose Insulin
- Sep 01, 2010: CEO Says Genzyme for Sale
- Sep 01, 2010: From Oranienburg to the rest of the world: global market launch of Daxas (Roflumilast) kicks off in Germany
- Sep 01, 2010: Gilead Provides Update on $5 Billion Stock Repurchase Program
- Sep 01, 2010: Pfizer to Acquire FoldRx Pharmaceuticals
- Sep 01, 2010: Allergan Resolves United States Government Investigation of Past Sales and Marketing Practices Relating to Certain Therapeutic Uses of Botox
- Sep 01, 2010: FDA Launches New Organizational Performance Management System
- Aug 31, 2010: Kentucky Attorney General Conway Announces $3.7 Million Settlement with Drug Company
- Aug 31, 2010: FDA Issues Warning to Baxter Over Drug Promotion
- Aug 31, 2010: Sun Pharma subsidiary receives warning letter from USFDA
- Aug 31, 2010: FDA Sends Sun Warning Letter Over Plant Conditions
- Aug 31, 2010: Online Health Advertisements Increasingly Trusted, Effective, 2010 About.com Health Study Finds
- Aug 31, 2010: GSK and Valeant Announce New U.S. FDA PDUFA Goal Date for Ezogabine
